FDA.reportPublic FDA data

tafasitamab-cxix 200 MG Injection

RxCUI
2387338
RxNorm name
tafasitamab-cxix 200 MG Injection
Display name
tafasitamab-cxix 200 MG Injection
Full name
tafasitamab-cxix 200 MG Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:10

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761163Monjuvitafasitamab-cxix351(a)Rx2026-06-01

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
9e0a220b-517f-4c86-b581-ffbab493fb58tafasitamab-cxix 200 MG InjectionPSN12These highlights do not include all the information needed to use MONJUVI safely and effectively. See full prescribing information for MONJUVI. MONJUVI ® (tafasitamab-cxix) for injection, for intravenous use Initial U.S. Approval: 202020250623
9e0a220b-517f-4c86-b581-ffbab493fb58tafasitamab-cxix 200 MG InjectionSCD12These highlights do not include all the information needed to use MONJUVI safely and effectively. See full prescribing information for MONJUVI. MONJUVI ® (tafasitamab-cxix) for injection, for intravenous use Initial U.S. Approval: 202020250623
ec13ac6b-bfde-4e84-907a-83bd69584d95tafasitamab-cxix 200 MG InjectionPSN10These highlights do not include all the information needed to use MONJUVI safely and effectively. See full prescribing information for MONJUVI. MONJUVI ® (tafasitamab-cxix) for injection, for intravenous use Initial U.S. Approval: 202020260202
ec13ac6b-bfde-4e84-907a-83bd69584d95tafasitamab-cxix 200 MG InjectionSCD10These highlights do not include all the information needed to use MONJUVI safely and effectively. See full prescribing information for MONJUVI. MONJUVI ® (tafasitamab-cxix) for injection, for intravenous use Initial U.S. Approval: 202020260202